Management of Dengue Fever in the Maldives
Dengue fever in the Maldives requires supportive care with careful fluid management and close monitoring for warning signs of severe disease—there is no specific antiviral treatment. 1
Diagnosis
Confirm dengue infection using:
- NS1 antigen detection (highly sensitive in acute phase, days 1-7) 1, 2
- PCR testing (early in illness, though NS1 antigen shows superior sensitivity) 1, 2
- IgM capture ELISA (after 5-7 days of symptoms) 1
Important caveat: The Maldives is dengue-endemic with year-round circulation and experienced a major outbreak in 2018 affecting over 3,200 people 3, 4. Maintain high clinical suspicion in any febrile patient.
Clinical Assessment
Classify Disease Severity
Uncomplicated dengue presents with:
- Fever with headache, retro-orbital pain, myalgia, arthralgia (especially back pain)
- Possible rash
- Laboratory findings: leukopenia, thrombocytopenia, elevated transaminases 1, 2
Warning signs indicating potential progression:
- Abdominal pain or tenderness
- Persistent vomiting
- Clinical fluid accumulation
- Mucosal bleeding
- Lethargy or restlessness
- Liver enlargement >2 cm
- Rising hematocrit with rapid platelet decline 5
Severe dengue (medical emergency):
- Severe plasma leakage leading to shock or respiratory distress
- Severe bleeding
- Severe organ impairment 5
Management Algorithm
For Uncomplicated Dengue (Outpatient)
Supportive care:
- Antipyretics: Paracetamol (acetaminophen) for fever control 6
- AVOID aspirin and NSAIDs (bleeding risk)
- Hydration: Encourage oral fluid intake; use oral rehydration solution (ORS) if signs of dehydration 6
- Rest
Monitoring:
- Daily clinical assessment until fever subsides and 24-48 hours into defervescence (critical period)
- Watch for warning signs
- Complete blood count monitoring for hematocrit and platelet trends 5
For Dengue with Warning Signs (Hospitalize)
Intravenous fluid management 5:
- Initiate IV crystalloids (isotonic solutions)
- Careful fluid administration to prevent both under-resuscitation and fluid overload
- Monitor hematocrit, vital signs, urine output closely
- Critical: Patients are at risk for plasma leakage; judicious fluid therapy is essential
For Severe Dengue (ICU Admission)
- Aggressive fluid resuscitation for shock
- Blood transfusion if severe bleeding or severe anemia
- Organ support as needed
- Intensive monitoring 5
Special Considerations in the Maldives
G6PD deficiency: Common genetic red blood cell disorders exist in the Maldives, including G6PD deficiency 7. In G6PD-deficient patients, dengue can trigger:
- Hemolytic anemia
- Rhabdomyolysis
- Dark urine, jaundice
- Monitor creatine kinase and manage complications accordingly 7
Co-infections: During the COVID-19 pandemic, dengue-SARS-CoV-2 coinfections were documented in the Maldives 4. When treating coinfection:
- Exercise extreme caution with IV fluids (COVID-19 patients prone to pulmonary edema)
- Look for dengue-specific findings: hemoconcentration, thrombocytopenia, AST > ALT pattern
- Confirm dengue serology to avoid false positivity 4
Key Clinical Pitfalls
Fluid management errors: Both under- and over-resuscitation cause complications. The critical period is during defervescence when plasma leakage peaks 5
Medication errors: Never use aspirin or NSAIDs—use only paracetamol for fever 6
Missed warning signs: The transition from uncomplicated to severe dengue occurs rapidly during the critical phase (defervescence period). Daily monitoring is mandatory 5
Delayed diagnosis: In endemic areas like the Maldives, maintain high suspicion for dengue in any acute febrile illness. NS1 antigen testing is more sensitive than PCR in acute phase 2
Neglecting other diagnoses: Consider malaria and other tropical diseases in the differential, though dengue is the most common arboviral infection in returning travelers from Asia 1
Follow-up
- Monitor complete blood count until normalization
- Clinical follow-up until complete recovery
- Patient education on warning signs and when to return immediately